Who owns Reata Pharmaceuticals Inc Cl A stock?

Tip: Access positions for across all investors

Analyze quarterly positions in Reata Pharmaceuticals Inc Cl A with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Reata Pharmaceuticals Inc Cl A stock

Who bought or sold Reata Pharmaceuticals Inc Cl A stock this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Public Employees' Retirement Association of Colorado 94k $1.6M 2642% Sep 2023
 View chart

Who sold out of Reata Pharmaceuticals Inc Cl A?

Fund or Company Name Date Sold Shares Held Valued At
BlackRock Jun 2023 2.5M $259M
Adage Capital Partners GP Jun 2023 1.8M $180M
State Street Corporation Jun 2023 713k $73M
Susquehanna International Jun 2023 608k $62M
Geode Capital Management Jun 2023 593k $61M
Farallon Capital Management Jun 2023 452k $46M
Invesco Jun 2023 341k $35M
Ing Investment Management Jun 2023 326k $33M
Sofinnova Ventures Jun 2023 323k $33M
FMR Jun 2023 305k $31M
Northern Trust Jun 2023 288k $29M
MPM Oncology Impact Management Jun 2023 235k $24M
Woodline Partners Jun 2023 205k $21M
Morgan Stanley Jun 2023 163k $17M
Ensign Peak Advisors Jun 2023 127k $13M
Integral Health Asset Management Jun 2023 120k $12M
Suvretta Capital Management Jun 2023 109k $11M
Ally Bridge Group Jun 2023 106k $11M
Driehaus Capital Management Jun 2023 95k $9.7M
Skandinaviska Enskilda Banken AB Jun 2023 95k $9.7M
Nuveen Asset Management Jun 2023 94k $9.6M